Business Context and Reporting Period
Company: Companhia Paranaense de Energia (COPEL / Energy Company of Paraná)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: March 18, 2026 (Reporting period: March 2026)
Context: COPEL announced its success in the LRCAP 2026 Capacity Reserve Auction, securing contracts for two hydro power plants: Foz do Areia (FDA) and Segredo.
Key Financial Metrics and Project Details
The filing details specific project metrics rather than consolidated financial statements for the period. Key data points include:
- Total Capacity Contracted: 1,862.8 MW (FDA: 690.470 MW; Segredo: 1,172.344 MW).
- Contract Term: 15 years for both projects.
- Contracted Gross Price: R$ 1,395.00 thousand/MW/year (indexed to IPCA, base date Sept 2025).
- Estimated Investment: R$ 1.3 billion (FDA) and R$ 3.6 billion (Segredo).
- Estimated Leverage: 70% for both projects.
- Start of Operations: Scheduled for August 2030.
Note: The filing does not provide consolidated revenue, profit, cash flow, or liquidity metrics for the reporting period.
Material Changes and Strategic Impact
This filing represents a material strategic development rather than a change in historical financial performance. The successful auction win:
- Strengthens the competitiveness of COPEL's portfolio.
- Enhances system operational flexibility.
- Creates opportunities for organic growth.
- Increases the value of existing assets through fixed gross revenue streams.
Guidance, Outlook, and Risks
Outlook: Management views these projects as a step in executing a high-value creation strategy with controlled risks. Operations are expected to commence in August 2030.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Actual results may differ materially due to:
- General economic and market conditions.
- Industry conditions and operating factors.
- Changes in assumptions regarding capital expenditure and financing strategies.
- Indexation risks (IPCA/IGPM) affecting contracted prices and transmission fees.
Investor Verification Checklist
- Verify the final execution of the 15-year power purchase agreements for FDA and Segredo.
- Monitor the progress of the estimated R$ 4.9 billion total investment against the 2030 operational timeline.
- Track the impact of IPCA and IGPM index variations on the contracted gross prices and Transmission System Usage Fees (TUST).
- Confirm the 70% leverage structure and associated financing terms for the new projects.
- Review future filings for updates on the physical guarantee related to expansion (20.6 MW for FDA, 56.3 MW for Segredo).